东曜药业-B股价拉升12.12% 市值涨1.73亿港元

市场透视11-29

2024年11月29日早盘11时15分，东曜药业-B（01875.hk）股票出现波动，股价大幅拉升12.12%。截至发稿，该股报1.850港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出740港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润3,925.86万港元，每股收益数据暂无，毛利数据暂无，市盈率-34.31倍。机构评级方面，在所有1家...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2487080633?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-29 11:15","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2487080633","market":"hk","top_or_hot":-1,"title":"东曜药业-B股价拉升12.12% 市值涨1.73亿港元","media":"市场透视","content":"<div>\n<p>2024年11月29日早盘11时15分，东曜药业-B（01875.hk）股票出现波动，股价大幅拉升12.12%。截至发稿，该股报1.850港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出740港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润3,925.86万港元，每股收益数据暂无，毛利数据暂无，市盈率-34.31倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>东曜药业-B股价拉升12.12% 市值涨1.73亿港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n东曜药业-B股价拉升12.12% 市值涨1.73亿港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-29 11:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024年11月29日早盘11时15分，东曜药业-B（01875.hk）股票出现波动，股价大幅拉升12.12%。截至发稿，该股报1.850港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出740港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润3,925.86万港元，每股收益数据暂无，毛利数据暂无，市盈率-34.31倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b","article_id":"2487080633","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2487080633","pubTimestamp":1732850119,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2024年11月29日早盘11时15分，东曜药业-B股票出现波动，股价大幅拉升12.12%。截至发稿，该股报1.850港元/股，成交量400股，换手率0.00%，振幅0.00%。东曜药业-B股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，东曜药业-B、荃信生物-B、百济神州涨幅较大，振幅较大的相关个股有晶泰科技、来凯医药-B、博安生物，振幅分别为10.20%、7.80%、6.83%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","01875":"东曜药业-B","BK1574":"生物医药B类股"},"translate_title":"TOT BIOPHARM-B's stock price rose 12.12%, and its market value rose by HK $173 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01875":0.9},"content_text":"2024年11月29日早盘11时15分，东曜药业-B（01875.hk）股票出现波动，股价大幅拉升12.12%。截至发稿，该股报1.850港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出740港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润3,925.86万港元，每股收益数据暂无，毛利数据暂无，市盈率-34.31倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。东曜药业-B股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，东曜药业-B、荃信生物-B、百济神州涨幅较大，振幅较大的相关个股有晶泰科技、来凯医药-B、博安生物，振幅分别为10.20%、7.80%、6.83%。东曜药业-B公司简介：东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。该公司的主营业务在中华人民共和国从事抗肿瘤药物的研究与开发、生产及营销、合约开发生产组织(CDMO)/合约生产组织(CMOJ)业务以及自主开发生物药物的对外许可。该公司拥有针对各类癌症的在研肿瘤药物管线,当中包括单克隆抗(mAb)及抗体偶联药物(ADC)。该公司已建立起一个集发现、产程开发、质量管理临床前及临床开发以及商业规模的生产基地和销售及营销能力于一体的综合内部平台。该公司主要在中国国内市场开展业务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2487080633"}